Filtros : " IQ005" "Pharmaceutics" Removido: "ARTES PLÁSTICAS" Limpar

Filtros



Refine with date range


  • Source: Pharmaceutics. Unidades: FCF, IQ

    Subjects: ESPECTROSCOPIA, NANOPARTÍCULAS

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      EULÁLIO, Denise et al. Development of dipeptide N–acetyl–L–cysteine loaded nanostructured carriers based on inorganic layered hydroxides. Pharmaceutics, v. 15, p. 1-25 art. 955, 2023Tradução . . Disponível em: https://doi.org/10.3390/pharmaceutics15030955. Acesso em: 16 ago. 2024.
    • APA

      Eulálio, D., Figueiredo, M. P., Gueho, C. T., Leroux, F., Serra, C. H. dos R., Faria, D. L. A. de, & Constantino, V. R. L. (2023). Development of dipeptide N–acetyl–L–cysteine loaded nanostructured carriers based on inorganic layered hydroxides. Pharmaceutics, 15, 1-25 art. 955. doi:10.3390/pharmaceutics15030955
    • NLM

      Eulálio D, Figueiredo MP, Gueho CT, Leroux F, Serra CH dos R, Faria DLA de, Constantino VRL. Development of dipeptide N–acetyl–L–cysteine loaded nanostructured carriers based on inorganic layered hydroxides [Internet]. Pharmaceutics. 2023 ; 15 1-25 art. 955.[citado 2024 ago. 16 ] Available from: https://doi.org/10.3390/pharmaceutics15030955
    • Vancouver

      Eulálio D, Figueiredo MP, Gueho CT, Leroux F, Serra CH dos R, Faria DLA de, Constantino VRL. Development of dipeptide N–acetyl–L–cysteine loaded nanostructured carriers based on inorganic layered hydroxides [Internet]. Pharmaceutics. 2023 ; 15 1-25 art. 955.[citado 2024 ago. 16 ] Available from: https://doi.org/10.3390/pharmaceutics15030955
  • Source: Pharmaceutics. Unidades: FCF, IQ, FCFRP

    Subjects: ANTIOXIDANTES, METABOLISMO

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      TAVARES, Renata Spagolla Napoleão et al. Skin irritation Testing beyond tissue viability: fucoxanthin effects on inflammation, homeostasis, and metabolism. Pharmaceutics, v. 12, n. 2, p. 1-12 art. 136, 2020Tradução . . Disponível em: https://doi.org/10.3390/pharmaceutics12020136. Acesso em: 16 ago. 2024.
    • APA

      Tavares, R. S. N., Maria-Engler, S. S., Colepicolo, P., Debonsi, H. M., Schäfer-Korting, M., Marx, U., et al. (2020). Skin irritation Testing beyond tissue viability: fucoxanthin effects on inflammation, homeostasis, and metabolism. Pharmaceutics, 12( 2), 1-12 art. 136. doi:10.3390/pharmaceutics12020136
    • NLM

      Tavares RSN, Maria-Engler SS, Colepicolo P, Debonsi HM, Schäfer-Korting M, Marx U, Gaspar LR, Zoschke C. Skin irritation Testing beyond tissue viability: fucoxanthin effects on inflammation, homeostasis, and metabolism [Internet]. Pharmaceutics. 2020 ; 12( 2): 1-12 art. 136.[citado 2024 ago. 16 ] Available from: https://doi.org/10.3390/pharmaceutics12020136
    • Vancouver

      Tavares RSN, Maria-Engler SS, Colepicolo P, Debonsi HM, Schäfer-Korting M, Marx U, Gaspar LR, Zoschke C. Skin irritation Testing beyond tissue viability: fucoxanthin effects on inflammation, homeostasis, and metabolism [Internet]. Pharmaceutics. 2020 ; 12( 2): 1-12 art. 136.[citado 2024 ago. 16 ] Available from: https://doi.org/10.3390/pharmaceutics12020136

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024